PART I Business Overview The Company, headquartered in Cranford, New Jersey, is a biopharmaceutical company focused on developing and commercializing innovative targeted oncology therapies. The Companys strategy centers on achieving a market leading position by advancing innovative therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs w...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-12-23 | 2025-09-30 | 0001213900-25-125331 | EDGAR | 61K words |
| 2024-12-27 | 2024-09-30 | 0001213900-24-113150 | EDGAR | — |
| 2024-04-16 | 2023-12-31 | 0001493152-24-014850 | EDGAR | — |
| 2023-04-17 | 2022-12-31 | 0001493152-23-012545 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-13 | 2025-12-31 | 0001213900-26-015877 | EDGAR | 15K words |
| 2025-08-12 | 2025-06-30 | 0001213900-25-074992 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0001213900-25-043359 | EDGAR | — |
| 2025-02-14 | 2024-12-31 | 0001213900-25-014320 | EDGAR | — |
| 2024-08-09 | 2024-06-30 | 0001493152-24-030991 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001493152-24-020783 | EDGAR | — |
| 2023-11-20 | 2023-09-30 | 0001493152-23-042170 | EDGAR | — |
| 2023-08-16 | 2023-06-30 | 0001493152-23-029131 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017394 | EDGAR | — |
| 2022-11-28 | 2022-09-30 | 0001493152-22-033847 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001213900-26-037501 | EDGAR | 3K words |
| 2026-03-10 | 0001213900-26-025464 | EDGAR | — |
| 2026-03-04 | 0001213900-26-023440 | EDGAR | — |
| 2026-02-13 | 0001213900-26-015894 | EDGAR | — |
| 2025-12-23 | 0001213900-25-125418 | EDGAR | — |
| 2025-12-10 | 0001213900-25-120197 | EDGAR | — |
| 2025-12-01 | 0001213900-25-116764 | EDGAR | — |
| 2025-10-27 | 0001213900-25-102625 | EDGAR | — |
| 2025-10-23 | 0001213900-25-101737 | EDGAR | — |
| 2025-09-19 | 0001213900-25-089615 | EDGAR | — |
75 total filings indexed. 51 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001851484 |
| Ticker | CTOR |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.citiusonc.com |
| Listed | 2024-08-13 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report